Stay updated on Study CB-839 + Paclitaxel in TNBC: Clinical Trial

Sign up to get notified when there's something new on the Study CB-839 + Paclitaxel in TNBC: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Study CB-839 + Paclitaxel in TNBC: Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The ClinicalTrials.gov page’s footer revision marker changed from v3.8.0 to v3.8.1.
    Difference
    0.0%
    Check dated 2026-11-22T13:19:14.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    The record presents details of a completed Phase 2 trial combining CB-839 with paclitaxel for advanced triple-negative breast cancer, including its participant cohorts, eligibility criteria, and study outcomes. It also includes study locations, record dates, and supporting documents.
    Difference
    71%
    Check dated 2026-11-08T12:32:03.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0. The study record still displays a 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-11-01T13:13:42.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition from the term “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T13:07:47.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T14:06:46.000Z thumbnail image
  7. Check
    42 days ago
    Change Detected
    Summary
    The site footer revision label changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T14:19:33.000Z thumbnail image

Stay in the know with updates to Study CB-839 + Paclitaxel in TNBC: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Study CB-839 + Paclitaxel in TNBC: Clinical Trial page.